CN101244158A - Chinese medicinal herb for effectively treating cirrhosis, liver ascites - Google Patents
Chinese medicinal herb for effectively treating cirrhosis, liver ascites Download PDFInfo
- Publication number
- CN101244158A CN101244158A CNA2008100074137A CN200810007413A CN101244158A CN 101244158 A CN101244158 A CN 101244158A CN A2008100074137 A CNA2008100074137 A CN A2008100074137A CN 200810007413 A CN200810007413 A CN 200810007413A CN 101244158 A CN101244158 A CN 101244158A
- Authority
- CN
- China
- Prior art keywords
- herba
- liver
- medicine
- treatment
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a Chinese herbal medicine, which enables the hepatopaths to get rid of harassment of liver ascites, liver cirrhosis, severe hepatitis b and other severe liver diseases effectively, can perfectly discharge the liver disease virus, and can reach the object of liver regeneration. The Chinese herbal medicine is made of polygonum cuspidate, Chinese mahonia, pyrrosia petiolosa, horseshoe fern, hypericum japonicum Thunb, herba artemisiae, verbena officinalis l, lap waste patrinia scabiosaefolia grass, kiwifruit, wild grape, aralia, sargentgloryvine stem, Chinese siphonostegia herb and other Chinese herbal medicines.
Description
Technical field
The present invention relates to a kind of Chinese herbal medicine, the Chinese herbal medicine of hepatopathys such as particularly a kind of effective treatment hepatic ascites, liver cirrhosis.
Background technology
The symptom of hepatitis mainly shows as, heating, weak, inappetence, feel sick, abdominal distention, diarrhoea, yellowish urine, skin and sclera (white of the eye) jaundice, the hepatic region is uncomfortable or pain etc.Chronic hepatitis has that nasal mucosa is hemorrhage, gingival hemorrhage, both legs swelling.Hepatitis gravis can occur that listlessness is depressed, dysphoria, sleep inversion, stupor etc.According to the statistics made by the departments concerned, China hepatitis B patient has 3,000 ten thousand at present, and hepatitis B virus carriers is 1.2 hundred million.Along with the quickening of people's rhythm of life, exceedingly drink, cause the alcoholic hepatitis sickness rate to increase, and ethanol not only can quicken chronic hepatitis such as hepatitis B greatly and changes into the process of liver cirrhosis, and can make healthy people directly drink into alcoholic cirrhosis, or cause hepatocarcinoma.Bad living habit and use medicine improperly causes the hepatitis due to medicine sickness rate also constantly to rise.
The doctor trained in Western medicine hepatopathy is normally checked what index was implemented to treat according to liver.With the treatment hepatitis B is example, and doctor trained in Western medicine is reducing serum alanine aminotransferase, and catharsis has harmful effect to liver but fall the enzyme medicine mostly, and the transaminase can rebound after the drug withdrawal, as re-uses and fall the enzyme medicine and then can cause the catharsis function of liver further to be destroyed.The patient who has paddy acyl transaminase rising can occur after using and falling the enzyme medicine, or bilirubin value seriously raises, hepatic fibrosis occurring is the liver cirrhosis omen, in this case, the enzyme medicine falls if continue to use doctor trained in Western medicine, liver function is made the matter worse beyond doubt, finally may cause liver cirrhosis, hepatic ascites even cancerate.To liver cirrhosis, hepatic ascites disease, doctor trained in Western medicine adopts diuretic or instillation albumin therapy usually, but general curative effect is not good enough, and the expense costliness.
Summary of the invention
The invention provides the tangible Chinese herbal medicine formula of a kind of therapeutic effect, it can play the puzzlement that effectively allows the hepatopath break away from serious hepatopathy such as hepatic ascites, liver cirrhosis, serious symptom hepatitis B, the intravital hepatopathy virus of patient can be discharged well, liver new life's purpose can also be reached.To protect the liver is principle, and various hepatopathys especially liver cirrhosis, mild or moderate hepatic ascites, serious symptom hepatitis B are had obvious curative effects, double early hepatocarcinoma, hepatitis B and the various types of hepatitis controlled.
The object of the present invention is achieved like this: a kind of Chinese herbal medicine for the treatment of hepatopathy, it mainly is grouped into by pressing the one-tenth that column weight amount percentage ratio takes by weighing: Mahonia fortunei (Lindl.) Fedde 8%-20%, Herba Hedyotidis Diffusae 3.5%-11%, patrima villosa 3.5%-11%, Herba Verbenae 3.5%-11%, pyrrosia petiolosaChing 3.5%-11%, Rhizoma Polygoni Cuspidati 8%-22%, Herba Hyperici Japonici 3.5%-20%, Rhizoma Angiopteridis Fokiensis 3.5%-20%, Herba Artemisiae Scopariae 3.5%-11%, Vitis Amurensis 6%-22%, Rhizoma Osmundae 3.5%-11%, Fructus actinidiae chinensis 6%-22%, Millettia Speciosa rattan 3.5%-8% Cortex araliae chinensis 8%-15%, Herba Plantaginis 4.5%-7%, Herba Siphonostegiae 2%-10%, Caulis Sargentodoxae 3.5%-11%.
To patient, can add Ramulus Salicis Babylonicae 4%-7%, Semen Maydis 4%-7%, Herba Glechomae 4%-7% with hepatic calculus.
To with the serious male patient of constipation, lockable sun 3.5%-9%.
The pharmacology of the used ingredient of the present invention is: 1, heat-clearing and toxic substances removing: Rhizoma Angiopteridis Fokiensis, Mahonia fortunei (Lindl.) Fedde, Herba Hyperici Japonici, Herba Verbenae, Rhizoma Osmundae, Herba Artemisiae Scopariae, patrima villosa grass; 2, relieving stranguria by diuresis: pyrrosia petiolosaChing, Herba Plantaginis, Rhizoma Polygoni Cuspidati, Herba Artemisiae Scopariae; 3, detumescence and apocenosis: Fructus actinidiae chinensis, Vitis Amurensis, Herba Verbenae, patrima villosa Cao , Cortex araliae chinensis; 4, eliminating carbuncle eliminating stagnation: Herba Glechomae, Herba Hedyotidis Diffusae, Ramulus Salicis Babylonicae, Semen Maydis, Millettia Speciosa rattan; 5, the living liver of invigorating blood circulation: Rhizoma Angiopteridis Fokiensis, Herba Hyperici Japonici, Rhizoma Polygoni Cuspidati, Mahonia fortunei (Lindl.) Fedde, Caulis Sargentodoxae, Herba Siphonostegiae; 6, protecting liver and expelling toxin: Herba Siphonostegiae, Rhizoma Angiopteridis Fokiensis; 7, adjuvant drug: Herba Cynomorii.
Chinese medicine of the present invention pharmaceutical methods routinely supports various dosage form, as is made into decoction, pill, powder etc.Certainly, can also make other suitable dosage forms, as long as but containing above-mentioned Chinese medicine ingredients promptly should think and belong to the present invention.
The invention has the beneficial effects as follows that protection patient liver makes patient's liver obtain new life, to reach the purpose of final treatment liver cirrhosis, hepatic ascites.Selected Chinese herbal medicine all has no side effect, and in the treatment hepatopathy, can patient's other internal organs and health not damaged.Curative effect is outstanding in actual applications, and cureless liver cirrhosis, hepatic ascites, serious symptom hepatitis B patient are had fabulous curative effect, can effectively get rid of the intravital toxin of patient, impels the hepatic ascites patient to get rid of hydrops in the body, promotes hepatocellular new life simultaneously.
The specific embodiment
Embodiments of the invention are pressed column weight amount percentage ratio and are taken by weighing: Mahonia fortunei (Lindl.) Fedde 12%, Herba Hedyotidis Diffusae 3.5%, patrima villosa 3.5%, Herba Verbenae 3.5%, pyrrosia petiolosaChing 10%, Rhizoma Polygoni Cuspidati 15%, Herba Hyperici Japonici 3.5%, Rhizoma Angiopteridis Fokiensis 3.5%, Herba Artemisiae Scopariae 3.5%, Vitis Amurensis 8%, Rhizoma Osmundae 3.5%, Fructus actinidiae chinensis 9%, Millettia Speciosa rattan 3.5% , Cortex araliae chinensis 8%, Herba Plantaginis 4.5%, Herba Siphonostegiae 2%, Caulis Sargentodoxae 3.5%.The crude drug of aforementioned proportion is amounted to 300 at every turn and restrain into Chinese medicine preparation (as decoction, powder) back and take for liver cirrhosis patient, clinography shows to have the obvious treatment effect.
Part of the present invention is cured case:
1, liver cirrhosis patient Wang: male, during treatment 31 years old, Zhangjiajie, Hunan Province day newspaper office edits, in July, 2004 cause serious symptom hepatitis B successively in the Zhangjiajie, the hospitalize on ground such as Changsha, Beijing, the back is transmitted and is hepatic encephalopathy, severe hepatic ascites, liver cirrhosis, hepatic coma repeatedly takes place during this time, reach more than 40 hour most, hospital issued the notice of repeatedly being critically ill.Rise in June, 2005 and accept the prescription treatment, through 20 months decoction treatment, existing liver form was recovered normally fully, and liver function takes a turn for the better comprehensively, now is convalescence.
2, liver cirrhosis patient Song: the male, during treatment 29 years old, teacher in the Sangzhi County, Hunan Province one, the summer in 2005 because of the serious symptom hepatitis B successively in the Sangzhi County, the hospitalize on ground such as Zhangjiajie, Changsha, after transfer hepatic ascites, liver cirrhosis to.Autumn in 2005 began to accept the prescription treatment, and through 18 months decoction treatment, it is normal that the liver form is recovered, and liver function takes a turn for the better comprehensively, now is convalescence.
3, liver cirrhosis patient accords with certain: the women, during treatment 27 years old, people from Zhangjiajie, Hunan Province checked and to find to suffer from liver cirrhosis in 1998, through the long-term treatment commentaries on classics of not getting better.Rise in August, 2006 and accept the decoction treatment, the treatment through 14 months, the liver form is near normal, and liver function greatly takes a turn for the better, and has not had tangible liver cirrhosis sign, now is consolidation.
4, liver cirrhosis patient Gong: the male, during treatment 53 years old, people from Zhangjiajie, Hunan Province checked and to find suffering from liver cirrhosis in 1998, do not have effect through long-term treatment.Rise in August, 2007 and accept the decoction treatment, through the treatment of two wheat harvesting periods, existing spirit is clearly better, and useful variation is just taking place the liver form, and the improvement sign appears in liver function, and is existing for strengthening the treatment phase.
5, liver cirrhosis patient foxtail millet, the male, during treatment 39 years old, the work of Yongding District detention house, Zhangjiajie City, Hunan Province, receive treatment in July, 2007, takes medicine three months over, and existing ascites disappears, and the liver cirrhosis improving situation is the reinforcement treatment phase.
6, liver cirrhosis patient Lee, the male, during treatment 45 years old, prosperous people from village in Zhangjiajie City, Hunan Province Yongding District Jiao Ziya town, now 59 years old, not only not morbidity can also be engaged in ass work after the rehabilitation.
7, the liver abscess patient deep certain, the male, during treatment 30 years old, Zhangjiajie City, Hunan Province Wulingyuan District Zhong Hu township Tan Mu hilllock people from village, now 43 years old, all were normal after the rehabilitation, give birth to children.
8, serious symptom hepatitis B patient Zhang, the male, during treatment 20 years old, Zhangjiajie City, Hunan Province Wulingyuan District people, begin to receive treatment in July, 2007, existing at that time slight ascites, through the treatment of four first quarter moons, rehabilitation now, and hepatitis B surface antigen detects and is negative.
9, liver cirrhosis patient Zhang, the male, during treatment 47 years old, Wulingyuan District Mt. Tianzi, Zhangjiajie City, Hunan Province from town now 50 years old, returned to one's perfect health.
10, liver cirrhosis patient Huang, the women, during treatment 45 years old, Zhangjiajie City, Hunan Province Yongding District sand barrier village people, ascites, begin to receive treatment in August, 2007, and existing ascites slowly disappears, and the liver cirrhosis situation takes a turn for the better, and is to strengthen the treatment phase.
Claims (6)
1, a kind of medicine for the treatment of hepatopathy, it is mainly formed by pressing the crude drug that column weight amount percentage ratio takes by weighing: Mahonia fortunei (Lindl.) Fedde 8%-20%, Herba Hedyotidis Diffusae 3.5%-11%, patrima villosa 3.5%-11%, Herba Verbenae 3.5%-11%, pyrrosia petiolosaChing 3.5%-11%, Rhizoma Polygoni Cuspidati 8%-22%, Herba Hyperici Japonici 3.5%-20%, Rhizoma Angiopteridis Fokiensis 3.5%-20%, Herba Artemisiae Scopariae 3.5%-11%, Vitis Amurensis 6%-22%, Rhizoma Osmundae 3.5%-11%, Fructus actinidiae chinensis 6%-22%, Millettia Speciosa rattan 3.5%-8% Cortex araliae chinensis 8%-15%, Herba Plantaginis 4.5%-7%, Herba Siphonostegiae 2%-10%, Caulis Sargentodoxae 3.5%-11%.
2, medicine as claimed in claim 1 is characterized in that: its crude drug also has Ramulus Salicis Babylonicae 4%-7%, Semen Maydis 4%-7%, Herba Glechomae 4%-7%.
3, medicine as claimed in claim 1 is characterized in that: its crude drug also has Herba Cynomorii 3.5%-9%.
4, as the described medicine of claim 1-3, it is characterized in that: its dosage form is a decoction.
5, as the described medicine of claim 1-3, it is characterized in that: its dosage form is a pill.
6, as the described medicine of claim 1-3, it is characterized in that: its dosage form is a powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100074137A CN101244158B (en) | 2008-03-10 | 2008-03-10 | Chinese medicinal herb for effectively treating cirrhosis, liver ascites |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100074137A CN101244158B (en) | 2008-03-10 | 2008-03-10 | Chinese medicinal herb for effectively treating cirrhosis, liver ascites |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101244158A true CN101244158A (en) | 2008-08-20 |
CN101244158B CN101244158B (en) | 2012-01-25 |
Family
ID=39944979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100074137A Expired - Fee Related CN101244158B (en) | 2008-03-10 | 2008-03-10 | Chinese medicinal herb for effectively treating cirrhosis, liver ascites |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101244158B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102091130A (en) * | 2010-11-25 | 2011-06-15 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating liver cirrhosis |
CN102362916A (en) * | 2011-09-30 | 2012-02-29 | 王发善 | Traditional Chinese medicinal compound extract product for protecting liver and preparation method thereof |
CN102688402A (en) * | 2012-06-01 | 2012-09-26 | 姜盛维 | Medicine for treating liver cirrhosis and liver ascites |
CN103385952A (en) * | 2013-06-30 | 2013-11-13 | 吴永清 | Drug for curing ascites due to cirrhosis |
CN105477194A (en) * | 2015-12-18 | 2016-04-13 | 吴福 | Traditional Chinese medicinal preparation for treating decompensated cirrhosis |
CN106390058A (en) * | 2016-08-12 | 2017-02-15 | 宁国洪 | Traditional Chinese medicinal composition for treating hepatic cirrhosis, liver ascites and liver nodule |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1150926C (en) * | 2001-10-11 | 2004-05-26 | 刘伟东 | Medicine for treating hepatism |
CN1269505C (en) * | 2003-12-23 | 2006-08-16 | 胡新国 | Medicine liqid for curing hepatopathy |
CN1329047C (en) * | 2005-05-29 | 2007-08-01 | 王福山 | Chinese medicinal composition for treating acute icterohepatitis |
CN1879786A (en) * | 2006-04-30 | 2006-12-20 | 胡硕泉 | A Chinese herbal medicament for treating hepatitis B |
-
2008
- 2008-03-10 CN CN2008100074137A patent/CN101244158B/en not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102091130A (en) * | 2010-11-25 | 2011-06-15 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating liver cirrhosis |
CN102362916A (en) * | 2011-09-30 | 2012-02-29 | 王发善 | Traditional Chinese medicinal compound extract product for protecting liver and preparation method thereof |
CN102688402A (en) * | 2012-06-01 | 2012-09-26 | 姜盛维 | Medicine for treating liver cirrhosis and liver ascites |
CN103385952A (en) * | 2013-06-30 | 2013-11-13 | 吴永清 | Drug for curing ascites due to cirrhosis |
CN103385952B (en) * | 2013-06-30 | 2015-03-11 | 吴永清 | Drug for curing ascites due to cirrhosis |
CN105477194A (en) * | 2015-12-18 | 2016-04-13 | 吴福 | Traditional Chinese medicinal preparation for treating decompensated cirrhosis |
CN106390058A (en) * | 2016-08-12 | 2017-02-15 | 宁国洪 | Traditional Chinese medicinal composition for treating hepatic cirrhosis, liver ascites and liver nodule |
Also Published As
Publication number | Publication date |
---|---|
CN101244158B (en) | 2012-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Seeff et al. | Complementary and alternative medicine in chronic liver disease | |
CN102114228B (en) | Traditional Chinese medicine preparation for externally treating cold-dampness arthralgia syndrome | |
CN101244158B (en) | Chinese medicinal herb for effectively treating cirrhosis, liver ascites | |
CN102526677A (en) | Chinese medicine foot-massage composition for treating common cold due to wind-cold | |
CN1970006A (en) | Chinese medicinal wine for treating piles and preparation process thereof | |
CN101062198A (en) | Decoction for treating arthritis | |
CN103142700A (en) | Externally applied liniment for treating premature ejaculation | |
CN101181380A (en) | Remedial medicament for relieving pain of rheumatism and preparation method thereof | |
CN101926903A (en) | Chinese medicine preparation for curing facial paralysis | |
CN104107264A (en) | Traditional Chinese medicine agent for treating infantile constipation and preparation method and application of traditional Chinese medicine agent | |
CN103479835A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
CN102579759B (en) | Shiteng rheumatalgia-relieving dampness removing liquor | |
CN101129637A (en) | Traditional Chinese Medicine for Treating Vascular Headache | |
Chong et al. | Recipes and general herbal formulae in books: causes of herbal poisoning | |
CN1069058C (en) | Compound medicament for treating chronic pelvic inflammation | |
CN101152542A (en) | Traditional Chinese medicine for treating cholestatic hepatitis | |
CN1274360C (en) | Antiphlogistic and antitussive medicine powder | |
CN103585545A (en) | Traditional Chinese medicine composition for treating otitis media | |
CN103446277B (en) | Traditional Chinese medicine composition for treating prostatitis by fumigating | |
CN111671841B (en) | Anti-osteoarthritis pharmaceutical composition and preparation method and application thereof | |
CN100586457C (en) | Chinese medicinal capsule for treating joint pain and hyperosteogeny | |
Okamoto et al. | Drug development with hints from traditional Indian Ayurveda medicine: hepatitis and rheumatoid as an example. | |
CN105617178A (en) | Traditional Chinese medicine composition for treating epidemic parotitis | |
CN100459986C (en) | Chinese medicine composition for treating rheumatoid disease | |
Singh et al. | Antiviral Herbs in Ayurveda |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120125 Termination date: 20200310 |